ホーム › がん（全種類） › ユタ › Salt Lake City
Salt Lake City、UTにおけるがん（全種類）の臨床試験
Salt Lake Cityとその周辺地域（約30マイル以内）の拠点で、がん（全種類）に関する27件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
被験者募集中第1/2相
- Intermountain - Primary Children's Hospital ( Site 4014), Salt Lake City
SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care
被験者募集中
- Huntsman Cancer Institute/ University of Utah, Salt Lake City
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
被験者募集中第3相
- Utah Cancer Specialists Cancer Center - Medical Oncology, Salt Lake City
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
被験者募集中第2相
- Intermountain Healthcare, Salt Lake City
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
被験者募集中第2/3相
- University of Utah - Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare - LDS Hospital, Salt Lake City
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
被験者募集中第1/2相
- Intermountain - Primary Children's Hospital ( Site 3014), Salt Lake City
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
被験者募集中第2相
- Huntsman Cancer Institute - University of Utah Health, Salt Lake City
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
被験者募集中第1/2相
- Huntsman Cancer Institute /ID# 271618, Salt Lake City
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
被験者募集中第1/2相
- Huntsman Cancer Institute, Salt Lake City
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- Primary Children's Hospital, Salt Lake City
Abatacept in Immune Checkpoint Inhibitor Myocarditis
被験者募集中第3相
- University of Utah, Salt Lake City
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
被験者募集中第3相
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
被験者募集中第1/2相
- Huntsman Cancer Institute /ID# 272575, Salt Lake City
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
被験者募集中第1相
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
被験者募集中
- Huntsman Cancer Institute at The University of Utah, Salt Lake City
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
被験者募集中
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
被験者募集中
- University of Utah Huntsman Cancer Institute (HCI), Salt Lake City
- University of Utah Primary Children's Hospital, Salt Lake City
Galleri® in the Medicare Population.
被験者募集中健康なボランティア歓迎
- HCA Healthcare St. Marks, Salt Lake City
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
被験者募集中第2相
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
被験者募集中
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Improving Health Insurance Literacy Among Young Adult Cancer Survivors
被験者募集中
- University of Utah, Salt Lake City
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
被験者募集中第1/2相
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
被験者募集中
- Huntsman Cancer Institute, Salt Lake City
Childhood Cancer Predisposition Study (CCPS)
被験者募集中観察研究
- Primary Children's Hospital, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Salt Lake City
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
被験者募集中観察研究
- Utah Cancer Specialists, Salt Lake City
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
被験者募集中
- Huntsman Cancer Institute (The University of Utah), Salt Lake City
他の都市におけるがん（全種類）の試験
- Houston, TX121件の研究
- New York City, NY109件の研究
- Boston, MA85件の研究
- Los Angeles, CA74件の研究
- Nashville, TN65件の研究
- Philadelphia, PA59件の研究
- Washington, DC58件の研究
- Durham, NC58件の研究
- Chicago, IL51件の研究
- Atlanta, GA49件の研究
- Seattle, WA49件の研究
- Arlington, VA48件の研究
Salt Lake Cityにおける他の研究
- 非小細胞肺癌31件の研究
- 乳がん27件の研究
- 大腸癌22件の研究
- 肺がん21件の研究
- 悪性黒色腫21件の研究
- 多発性骨髄腫21件の研究
- 転移性癌20件の研究
- 卵巣がん19件の研究
- 肥満症18件の研究
- 急性骨髄性白血病17件の研究
- 心不全17件の研究
- 前立腺がん15件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。